The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Editors' (re)View
Editors' (re)View
Editor’s (re)View: Novo Nordisk knew what it was getting in purchase of troubled Indiana site
While the plant was recently hit with the FDA’s most severe post-inspection classification, it is a facility that has been plagued with problems for several years.
Oct. 17, 2025
Editors' (re)View
Editor’s (re)View: Cell and gene therapy sector regroups amid tough 2025
Oct. 10, 2025
Editors' (re)View
Editor’s (re)View: Trump’s on-again, off-again pharma tariffs are getting old
Oct. 3, 2025
Editors' (re)View
Editor’s (re)View: North Carolina’s biomanufacturing building boom is also a challenge
Sept. 26, 2025
Editors' (re)View
Editor’s (re)View: Novo Nordisk isn’t pandering to Trump with US manufacturing pledge
Sept. 19, 2025
Editors' (re)View
Editor’s (re)View: Not a good week for India’s Sun Pharma and API manufacturer Hikal
Sept. 12, 2025
Editors' (re)View
Editor’s (re)View: It matters if Big Pharma is fudging its US investment numbers
Sept. 5, 2025
Editors' (re)View
Editor’s (re)View: Watch out China, India’s CRDMOs have you in their crosshairs
Aug. 29, 2025
Editors' (re)View
Editor’s (re)View: What J&J’s $2B US manufacturing investment says about Trump’s tariff-driven onshoring strategy
Aug. 22, 2025
Looking for Something?
Load More Content
Back To Top